Skip to content
WeighLab

Tell Her Doc vs NexLife

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Tell Her Doc

Provider comparison

Women who want a well-documented, LegitScript-verified provider and will get the real recurring price before trusting the $269 headline.

Semaglutide / month
$269/moCompounded oral
Tirzepatide / month
Not disclosed
Index 69/100 · Grade CChecked August 2026

NexLife

Provider comparison

Shoppers who want a flat price at every dose, month to month or a little less on a longer plan.

Semaglutide / month
$139/moAll doses, monthly plan, compounded; $132/mo on a 3-month plan, $125/mo on 6 months, $119/mo on 12 months
Tirzepatide / month
$169/moAll doses, monthly plan, compounded; $159/mo on a 3-month plan, $149/mo on 6 months, $139/mo on 12 months
Index 69/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Both score 69/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.

Check the difference in state access

Tell Her Doc
All 50 states
NexLife
Coverage not published

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Tell Her Doc

NexLife

Semaglutide / month
Tell Her Doc: $269/moCompounded oral
NexLife: $139/moAll doses, monthly plan, compounded; $132/mo on a 3-month plan, $125/mo on 6 months, $119/mo on 12 months
Tirzepatide / month
Tell Her Doc: Not disclosed
NexLife: $169/moAll doses, monthly plan, compounded; $159/mo on a 3-month plan, $149/mo on 6 months, $139/mo on 12 months
Semaglutide / year (modeled)
Tell Her Doc: $3,228
NexLife: $1,668
Tirzepatide / year (modeled)
Tell Her Doc: —
NexLife: $2,028
State availability
Tell Her Doc: All 50 states
NexLife: Coverage not published
Oral / sublingual option listed
Tell Her Doc: Yes
NexLife: Not listed
Brand-name access listed
Tell Her Doc: Yes
NexLife: Not confirmed
Provider facts checked
Tell Her Doc: August 2026
NexLife: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Tell Her Doc

Women who want a well-documented, LegitScript-verified provider and will get the real recurring price before trusting the $269 headline.

Reasons to consider it

  • Four named, NPI-verified physicians -- unusually transparent medical leadership for this category
  • Four named compounding pharmacy partners (Belmar, Strive, Epiq Scripts, Casa Pharma Rx)
  • Claims and displays coverage across all 50 states

What to weigh up

  • Headline '$269 / $140 off' price is a prepaid, first-time-customer, oral-semaglutide-only promo -- not a general or recurring rate
  • No standalone tirzepatide price disclosed
  • Fine print restricting the discount is not visible from the homepage banner alone

NexLife

Shoppers who want a flat price at every dose, month to month or a little less on a longer plan.

Reasons to consider it

  • Flat pricing at every dose for both drugs, with no per-mg increase as the dose goes up, unlike most compounded programs we track
  • LegitScript certified with a named medical director (Adam Kennah, M.D.)
  • States every batch undergoes independent third-party testing for potency, sterility, pH, and endotoxin levels

What to weigh up

  • Cancellations take effect after 30 days, so expect to pay for one more shipment
  • No individual compounding pharmacy is named, only 'LegitScript-certified, NABP-accredited' pharmacies generically
  • No Certificate of Analysis (COA) is linked despite the batch-testing claim

Regulatory note: the FDA issued a warning letter to Nexlife Inc. dba Nexlife in June 2026. We still list and link to NexLife; you should know the letter is on the public record before you decide.

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

Tell Her DocNexLife
Normalized Cost/Month
Tell Her Doc:
45/100
NexLife:
87/100
Price Transparency
Tell Her Doc:
78/100
NexLife:
94/100
Nationwide Access
Tell Her Doc:
86/100
NexLife:
24/100
Formulation Options
Tell Her Doc:
77/100
NexLife:
66/100
Clinical Oversight
Tell Her Doc:
76/100
NexLife:
76/100
Contract Flexibility
Tell Her Doc:
61/100
NexLife:
55/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.